发明名称 Methionine restriction for cancer therapy
摘要 The present invention is directed to methods and compositions regarding induction of apoptosis in a cell and treatment of cancer in an individual wherein methionine deprivation of the cell is followed by methionine repletion of the cell. The methionine deprivation of the cell results in G2 arrest in the cell, leading to DNA damage in the cell. Upon readministration of methionine to the cell, the damaged cell exits G2 arrest and enters into apoptosis. In a specific embodiment, a therapeutic effect is elicited by cycling the patient between a methionine-depleted diet and a normal, methionine-replete diet. The present invention also regards chronic methionine deprivation for treatment of cancer in a human, in addition to methods for methionine restriction as adjunctive therapy for other cancer treatment methods.
申请公布号 US2003129262(A1) 申请公布日期 2003.07.10
申请号 US20020231562 申请日期 2002.08.30
申请人 EPNER DANIEL E.;BAXTER JEFFREY H.;KIVI JEFFREY T.;HARDS ROBERT G. 发明人 EPNER DANIEL E.;BAXTER JEFFREY H.;KIVI JEFFREY T.;HARDS ROBERT G.
分类号 A23L1/29;A23L1/305;A61K36/48;A61K38/16;A61K38/51;(IPC1-7):A61K38/48;A61K35/78 主分类号 A23L1/29
代理机构 代理人
主权项
地址